Literature DB >> 26621124

TRPV1 receptors augment basal synaptic transmission in CA1 and CA3 pyramidal neurons in epilepsy.

F Saffarzadeh1, M J Eslamizade1, S M M Mousavi2, S B Abraki2, M R Hadjighassem3, A Gorji4.   

Abstract

Temporal lobe epilepsy in human and animals is attributed to alterations in brain function especially hippocampus formation. Changes in synaptic activity might be causally related to the alterations during epileptogenesis. Transient receptor potential vanilloid 1 (TRPV1) as one of the non-selective ion channels has been shown to be involved in synaptic transmission. However, the potential role of TRPV1 receptors in synaptic function in the epileptic brain needs to be elucidated. In the present study, we used quantitative real-time PCR (qRT-PCR), western blotting, and immunohistochemistry to assess hippocampal TRPV1 mRNA expression, protein content, and distribution. Moreover, the effects of pharmacologic activation and inhibition of TRPV1 receptors on the slope of evoked field excitatory postsynaptic potentials (fEPSPs) were analyzed in CA1 and CA3 pyramidal neurons, after 3months of pilocarpine-induced status epilepticus (SE). SE induced an upregulation of TRPV1 mRNA and protein content in the whole hippocampal extract, as well as its distribution in both CA1 and CA3 regions. Activation and inhibition of TRPV1 receptors (via capsaicin 1μM and capsazepine 10μM, respectively) did not influence basal synaptic transmission in CA1 and CA3 regions of control slices, however, capsaicin increased and capsazepine decreased synaptic transmission in both regions in tissues from epileptic animals. Taken together, these findings suggest that a higher expression of TRPV1 in the epileptic condition is accompanied by alterations in basal synaptic transmission.
Copyright © 2015 IBRO. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  CA1; CA3; TRPV1; hippocampus; synaptic transmission; temporal lobe epilepsy

Mesh:

Substances:

Year:  2015        PMID: 26621124     DOI: 10.1016/j.neuroscience.2015.11.045

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  12 in total

1.  The Highs and Lows of the Endocannabinoid System-Another Piece to the Epilepsy Puzzle?

Authors:  Jerzy P Szaflarski
Journal:  Epilepsy Curr       Date:  2018 Sep-Oct       Impact factor: 7.500

2.  Effects of a TRPV1 agonist capsaicin on respiratory rhythm generation in brainstem-spinal cord preparation from newborn rats.

Authors:  Mariho Tani; Sayumi Kotani; Chikara Hayakawa; Shih-Tien Lin; Saki Irie; Keiko Ikeda; Kiyoshi Kawakami; Hiroshi Onimaru
Journal:  Pflugers Arch       Date:  2016-11-29       Impact factor: 3.657

3.  Upregulated P2X3 Receptor Expression in Patients with Intractable Temporal Lobe Epilepsy and in a Rat Model of Epilepsy.

Authors:  Xin Zhou; Li-Min Ma; Yan Xiong; Hao Huang; Jin-Xian Yuan; Ruo-Han Li; Jia-Ni Li; Yang-Mei Chen
Journal:  Neurochem Res       Date:  2016-01-06       Impact factor: 3.996

Review 4.  Beneficial Effects of Capsaicin in Disorders of the Central Nervous System.

Authors:  Michał Pasierski; Bartłomiej Szulczyk
Journal:  Molecules       Date:  2022-04-12       Impact factor: 4.927

5.  TrpV1 receptor activation rescues neuronal function and network gamma oscillations from Aβ-induced impairment in mouse hippocampus in vitro.

Authors:  Hugo Balleza-Tapia; Sophie Crux; Yuniesky Andrade-Talavera; Pablo Dolz-Gaiton; Daniela Papadia; Gefei Chen; Jan Johansson; André Fisahn
Journal:  Elife       Date:  2018-11-12       Impact factor: 8.140

6.  Activation of TRPV1 Contributes to Recurrent Febrile Seizures via Inhibiting the Microglial M2 Phenotype in the Immature Brain.

Authors:  Weilin Kong; Xin Wang; Xingliang Yang; Wenxian Huang; Song Han; Jun Yin; Wanhong Liu; Xiaohua He; Biwen Peng
Journal:  Front Cell Neurosci       Date:  2019-10-11       Impact factor: 5.505

7.  Safety and Tolerability of Cannabidiol in Parkinson Disease: An Open Label, Dose-Escalation Study.

Authors:  Maureen A Leehey; Ying Liu; Felecia Hart; Christen Epstein; Mary Cook; Stefan Sillau; Jost Klawitter; Heike Newman; Cristina Sempio; Lisa Forman; Lauren Seeberger; Olga Klepitskaya; Zachrey Baud; Jacquelyn Bainbridge
Journal:  Cannabis Cannabinoid Res       Date:  2020-12-15

8.  The Expanding Therapeutic Potential of Neuronal KCC2.

Authors:  Bor Luen Tang
Journal:  Cells       Date:  2020-01-17       Impact factor: 6.600

9.  TRPV1 Contributes to the Neuroprotective Effect of Dexmedetomidine in Pilocarpine-Induced Status Epilepticus Juvenile Rats.

Authors:  Xingqin Tan; Yong Zeng; Zhenzhen Tu; Pan Li; Hengsheng Chen; Li Cheng; Shengfen Tu; Li Jiang
Journal:  Biomed Res Int       Date:  2020-04-07       Impact factor: 3.411

Review 10.  Insights into Potential Targets for Therapeutic Intervention in Epilepsy.

Authors:  Cecilia Zavala-Tecuapetla; Manola Cuellar-Herrera; Hiram Luna-Munguia
Journal:  Int J Mol Sci       Date:  2020-11-13       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.